SIRT1 and neoplasm: In vivo evidence from mouse xenografts injected with the double knockdown cells revealed that the ablation of SIRT1 expression counteracted the effects of SIRT4 decline on tumor growth (Figure 6E-G), which is consistent with the IHC data of Ki67 staining (Figure S13C).